Current therapy for bacterial keratitis and bacterial conjunctivitis

Therapy of bacterial keratitis and conjunctivitis requires that antibiotics be administered to eliminate viable bacteria. Only a limited number of ophthalmic antibiotics are commercially available. Although generally adequate for the treatment of bacterial conjunctivitis, the commercial preparations...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of ophthalmology Vol. 112; no. 4 Suppl; p. 10S
Main Author:	Steinert, R F
Format:	Journal Article
Language:	English
Published:	United States 01-10-1991
Subjects:	Administration, Topical Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Bacterial Infections - drug therapy Conjunctivitis - drug therapy Conjunctivitis - microbiology Drug Combinations Forecasting Humans Keratitis - drug therapy Keratitis - microbiology
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Therapy of bacterial keratitis and conjunctivitis requires that antibiotics be administered to eliminate viable bacteria. Only a limited number of ophthalmic antibiotics are commercially available. Although generally adequate for the treatment of bacterial conjunctivitis, the commercial preparations are believed to contain too low a concentration of antibiotic for the treatment of bacterial keratitis. Using products designed for parenteral administration, the ophthalmologist or the pharmacist formulates so-called fortified preparations containing much higher antibiotic concentrations. Because of their limited spectrum of action, two fortified preparations generally are administered concurrently. Topical application is the most effective route of antibiotic administration for treatment of bacterial keratitis. Antibiotics may also be injected periocularly, a method with risk, or intravenously, a method of uncertain efficacy.
ISSN:	0002-9394